Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Plos One
|
June 13, 2017
A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease
Boris Hayete, Diane Wuest, Jason Laramie, et al.
The Lancet. Neurology
|
April 13, 2011
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
Olivier Rascol, Cheryl J Fitzer-Attas, Robert Hauser, et al.
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics
|
March 24, 2006
Contemporary assessment and pharmacotherapy of Tourette syndrome
Lawrence Scahill, Gerald Erenberg, Cheston M Berlin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 14, 2011
Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease
Andrew Lees, Stanley Fahn, Karla M Eggert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 18, 2017
Nomenclature of genetic movement disorders: Recommendations of the International Parkinson and Movement Disorder Society task force
Connie Marras, Anthony Lang, Bart P van de Warrenburg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 16, 2016
Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force
Connie Marras, Anthony Lang, Bart P van de Warrenburg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 14, 2016
Reply letter to Jinnah "Locus pocus" and Albanese "Complex dystonia is not a category in the new 2013 consensus classification": Necessary evolution, no magic!
Christine Klein, Anthony Lang, Bart P van de Warrenburg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 7, 2012
The pill questionnaire in a nondemented Parkinson's disease population
William Reginold, Melissa J Armstrong, Sarah Duff-Canning, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 30, 2010
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease
Steven R Schwid, Janice Bausch, David Oakes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 29, 2023
Isolated Cervical Dystonia: Diagnosis and Classification
Alberto Albanese, Kailash P Bhatia, Francisco Cardoso, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Plos One
|
June 13, 2017
A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease
Boris Hayete, Diane Wuest, Jason Laramie, et al.
The Lancet. Neurology
|
April 13, 2011
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
Olivier Rascol, Cheryl J Fitzer-Attas, Robert Hauser, et al.
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics
|
March 24, 2006
Contemporary assessment and pharmacotherapy of Tourette syndrome
Lawrence Scahill, Gerald Erenberg, Cheston M Berlin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 14, 2011
Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease
Andrew Lees, Stanley Fahn, Karla M Eggert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 18, 2017
Nomenclature of genetic movement disorders: Recommendations of the International Parkinson and Movement Disorder Society task force
Connie Marras, Anthony Lang, Bart P van de Warrenburg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 16, 2016
Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force
Connie Marras, Anthony Lang, Bart P van de Warrenburg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 14, 2016
Reply letter to Jinnah "Locus pocus" and Albanese "Complex dystonia is not a category in the new 2013 consensus classification": Necessary evolution, no magic!
Christine Klein, Anthony Lang, Bart P van de Warrenburg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 7, 2012
The pill questionnaire in a nondemented Parkinson's disease population
William Reginold, Melissa J Armstrong, Sarah Duff-Canning, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 30, 2010
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease
Steven R Schwid, Janice Bausch, David Oakes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 29, 2023
Isolated Cervical Dystonia: Diagnosis and Classification
Alberto Albanese, Kailash P Bhatia, Francisco Cardoso, et al.
Page
of 8